Posted by Donna Armstrong | Jun 4th, 2018
Mesoblast limited (NASDAQ:MESO) – Equities research analysts at Oppenheimer upped their FY2018 earnings estimates for Mesoblast in a report released on Thursday, May 31st. Oppenheimer analyst M. Breidenbach now expects that the company will post earnings per share of ($0.38) for the year, up from their previous estimate of ($0.45). Oppenheimer also issued estimates for Mesoblast’s Q4 2018 earnings at ($0.23) EPS, Q1 2019 earnings at ($0.21) EPS, Q2 2019 earnings at ($0.23) EPS, Q4 2019 earnings at ($0.25) EPS, FY2019 earnings at ($0.92) EPS, FY2020 earnings at ($0.56) EPS and FY2021 earnings at $1.59 EPS.
Oppenheimer Analysts Raise Earnings Estimates for Mesoblast limited (MESO)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |